Harvard Bioscience (HBIO) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.05% |
| Dec 31, 2025 | 47.64% |
| Sep 30, 2025 | -18.17% |
| Jun 30, 2025 | -20.65% |
| Mar 31, 2025 | 16.31% |
| Dec 31, 2024 | -7.23% |
| Sep 30, 2024 | 19.91% |
| Jun 30, 2024 | 23.91% |
| Mar 31, 2024 | 35.16% |
| Dec 31, 2023 | 54.27% |
| Sep 30, 2023 | -3.33% |
| Jun 30, 2023 | 29.67% |
| Mar 31, 2023 | -14.60% |
| Dec 31, 2022 | 1.99% |
| Sep 30, 2022 | 12.99% |
| Jun 30, 2022 | 13.08% |
| Mar 31, 2022 | 18.92% |
| Dec 31, 2021 | 16.56% |
| Sep 30, 2021 | -18.34% |
| Jun 30, 2021 | 18.55% |
| Mar 31, 2021 | -5.56% |
| Dec 31, 2020 | 15.01% |
| Sep 30, 2020 | -3.04% |
| Jun 30, 2020 | -36.23% |
| Mar 31, 2020 | 17.41% |
| Dec 31, 2019 | 20.69% |
| Sep 30, 2019 | 22.33% |
| Jun 30, 2019 | 21.11% |
| Mar 31, 2019 | 20.18% |
| Dec 31, 2018 | 16.85% |
| Sep 30, 2018 | 20.21% |
| Jun 30, 2018 | 21.15% |
| Mar 31, 2018 | 27.68% |
| Dec 31, 2017 | 18.58% |
| Sep 30, 2017 | 19.57% |
| Jun 30, 2017 | 22.54% |
| Mar 31, 2017 | 21.67% |
| Dec 31, 2016 | -46.21% |
| Sep 30, 2016 | 45.95% |
| Jun 30, 2016 | -7.40% |
| Mar 31, 2016 | 19.65% |
| Dec 31, 2015 | -87.15% |
| Sep 30, 2015 | 41.02% |